ASGCT 2025 is on the horizon, and LumaCyte is thrilled to participate and collaborate with the some of the brightest minds in gene and cell therapy. By leveraging our cutting-edge Label-free Cellular Process Analytical Technology (PAT), we’re committed to doing our part to

Are you driven by opportunities to breakthrough status quo barriers? Do you believe advanced analytics have the ability to revolutionize the future of bioprocess and manufacturing outcomes? Are you located in Boston? If so, than LumaCyte is looking for YOU!. Join LumaCyte as a

Beyond Viability: Healthier Cells, Better Therapies. What if cell health wasn’t just viable, but optimal? Discover how advanced technologies are reshaping cell therapy by redefining viability. Dive into the future of healthier, more robust cells: 

Don't Miss Out!. Join Renee A. Hart from LumaCyte on May 8th at 5 PM for an engaging panel discussion at the ISCT Annual Meeting:"Can Cellular Starting Material Predict Therapeutic Outcomes." Be part of the conversation as industry leaders dive into this pioneering topic and

Revolutionizing Cell Health Monitoring in Biomanufacturing .Learn how Laser Force Cytology™ (LFC) is transforming bioprocessing! Our latest technote explores how the Radiance® instrument provides real-time, label-free insights into cellular health under oxidative stress—offering

Advancing Vaccine Production: Key Insights from Our Webinar.Scientists from Thermo Fisher Scientific and LumaCyte achieved a 10-fold increase in viral titer using the Gibco™ Adherent Kidney Media Panel, designed to support Vero cells in vaccine and viral vector applications. The

Unlock the Power of Precision Analytics with Radiance by LumaCyte!.Experience unparalleled accuracy and efficiency in your biomanufacturing processes with LumaCyte's advanced precision analytics and Radiance platform. Our cutting-edge technology ensures real-time monitoring and

Transform Your Biomanufacturing with Label-Free Cellular PAT Analytics!.Achieve heightened production consistency and maximize product yields through cutting-edge real-time monitoring. Ready to elevate your processes?. Learn more here:  #Biomanufacturing

Revolutionize CAR-T Therapy Development and Manufacturing with LumaCyte's Predictive Donor & Patient Screening Service.LumaCyte's Predictive Donor Screening Service utilizes Laser Force Cytology advanced analytics to characterize donor cells in real-time, enhancing consistency

Navigating the Future: Key Take Aways from Phacilitate ATW and CASSS WCBP. The Phacilitate Advanced Therapies Week (ATW) held January 20-23, 2025, in Dallas, Texas, and the CASSS Well Characterized Bioprocess (WCBP) held January 28-30, 2025, in Washington, D.C. highlighted the

Discover the future of precision analytics with LumaCyte at the WCBP 2025 conference on January 28-30, 2025 in Washington, DC. Join us for an in-person seminar titled "Quantitative Cell Characterization Using Laser Force Cytology™ (LFC): The Future of Precision Analytics for

Join the LumaCyte Team at Advanced Therapies Week next week in Dallas, Texas. Discover groundbreaking innovations and network with industry leaders at the premier event for advanced therapies. Don’t miss your chance to explore cutting-edge research, gain insights from the

We wish everyone a very bright and prosperous 2025. May this be the year our industry accelerates and achieves milestone level scientific advancements that drive significant growth across the sector. At LumaCyte we are proud to stand beside you lighting the path and delivering

As Christmas approaches, we celebrate the joy of discovery at LumaCyte. Each cell we analyze brings new insights and innovations, lighting up the world of analytics. Merry Christmas & Happy Holidays!

Event Recap: 6th Annual Cell Therapy Analytical Development Summit.What an incredible gathering at the Cell Therapy Analytical Development Summit! We were honored to have LumaCyte's President and CBO, Renee A. Hart, join industry leaders Ramon Mendoza, Alexandre Ambrogelly, and

Thank you Chris Spivey and BioPharm International for the invitation for LumaCyte’s CEO and CSO, Sean Hart, PhD to participate in this industry expert panel, Fixing the Potholes in CGT Manufacturing. Listen in to hear Dr. Peter Marks, from CBER FDA, Fabian Gerlinghaus, from

In a recent BiotechTV interview, Colin Hebert, Senior Vice President of Scientific & Business Operations at LumaCyte, discusses how Radiance's platform technology utilizes lasers for single cell analysis. Explore the groundbreaking impact of LumaCyte's Laser Force Cytology™

Join LumaCyte's President and CBO Renee Hart at the 6th Annual Cell Therapy Analytical Development Summit. She will join Ramon Mendoza, Alexandre Ambrogelly, and Stephan Krause for the Industry Leaders’ Fireside Chat: Pioneering Analytical Frontiers to Overcome the Complexities

We are excited to announce that Colin Hebert, Senior Vice President of Scientific & Business Operations at LumaCyte, will be presenting at the 6th Annual Cell Therapy Analytical Development Summit on Wednesday, December 4, 2024. Don't miss his presentation at 12:30 pm titled